Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Rodbard

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Diabetes Technology & Therapeutics|November 13, 2009
Improved quality of glycemic control and reduced glycemic variability with use of continuous glucose monitoringDavid Rodbard, Timothy Bailey, Lois Jovanovic, et al.
Journal of Diabetes Science and Technology|December 24, 2023
Response to Sensitivity of the Glycemia Risk Index to Effects of Automated Insulin Delivery InitiationDavid C Klonoff, Michael A Kohn, David Rodbard, et al.
JMIR Mhealth and Uhealth|December 1, 2017
One Drop | Mobile on iPhone and Apple Watch: An Evaluation of HbA1c Improvement Associated With Tracking Self-CareChandra Y Osborn, Joost R van Ginkel, David G Marrero, et al.
Diabetes Technology & Therapeutics|February 16, 2008
Usability test of an internet-based informatics tool for diabetes care providers: the comprehensive diabetes management programStephanie J Fonda, Christine A Paulsen, Joan Perkins, et al.
JMIR Diabetes|October 7, 2018
One Drop | Mobile: An Evaluation of Hemoglobin A1c Improvement Linked to App EngagementChandra Y Osborn, Joost R van Ginkel, David Rodbard, et al.
Diabetes Care|January 25, 2017
Comparison of Insulin Glargine 300 Units/mL and 100 Units/mL in Adults With Type 1 Diabetes: Continuous Glucose Monitoring Profiles and Variability Using Morning or Evening InjectionsRichard M Bergenstal, Timothy S Bailey, David Rodbard, et al.
Journal of Diabetes Science and Technology|January 15, 2019
The Relationships Between Time in Range, Hyperglycemia Metrics, and HbA1cRoy W Beck, Richard M Bergenstal, Peiyao Cheng, et al.
Diabetes Technology & Therapeutics|July 8, 2020
Glucose Variability and Time in Range in Type 2 Diabetes Treated with U-500R by Pump or Injection: CGM Findings from the VIVID StudyThomas Blevins, Wendy Lane, David Rodbard, et al.
Diabetes, Obesity & Metabolism|June 23, 2023
Association between glycaemia risk index (GRI) and diabetic retinopathy in type 2 diabetes: A cohort studyYaxin Wang, Jingyi Lu, Jiaying Ni, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 12, 2021
American Association of Clinical Endocrinology Clinical Practice Guideline: The Use of Advanced Technology in the Management of Persons With Diabetes MellitusGeorge Grunberger, Jennifer Sherr, Myriam Allende, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Diabetes Technology & Therapeutics|November 13, 2009
Improved quality of glycemic control and reduced glycemic variability with use of continuous glucose monitoringDavid Rodbard, Timothy Bailey, Lois Jovanovic, et al.
Journal of Diabetes Science and Technology|December 24, 2023
Response to Sensitivity of the Glycemia Risk Index to Effects of Automated Insulin Delivery InitiationDavid C Klonoff, Michael A Kohn, David Rodbard, et al.
JMIR Mhealth and Uhealth|December 1, 2017
One Drop | Mobile on iPhone and Apple Watch: An Evaluation of HbA1c Improvement Associated With Tracking Self-CareChandra Y Osborn, Joost R van Ginkel, David G Marrero, et al.
Diabetes Technology & Therapeutics|February 16, 2008
Usability test of an internet-based informatics tool for diabetes care providers: the comprehensive diabetes management programStephanie J Fonda, Christine A Paulsen, Joan Perkins, et al.
JMIR Diabetes|October 7, 2018
One Drop | Mobile: An Evaluation of Hemoglobin A1c Improvement Linked to App EngagementChandra Y Osborn, Joost R van Ginkel, David Rodbard, et al.
Diabetes Care|January 25, 2017
Comparison of Insulin Glargine 300 Units/mL and 100 Units/mL in Adults With Type 1 Diabetes: Continuous Glucose Monitoring Profiles and Variability Using Morning or Evening InjectionsRichard M Bergenstal, Timothy S Bailey, David Rodbard, et al.
Journal of Diabetes Science and Technology|January 15, 2019
The Relationships Between Time in Range, Hyperglycemia Metrics, and HbA1cRoy W Beck, Richard M Bergenstal, Peiyao Cheng, et al.
Diabetes Technology & Therapeutics|July 8, 2020
Glucose Variability and Time in Range in Type 2 Diabetes Treated with U-500R by Pump or Injection: CGM Findings from the VIVID StudyThomas Blevins, Wendy Lane, David Rodbard, et al.
Diabetes, Obesity & Metabolism|June 23, 2023
Association between glycaemia risk index (GRI) and diabetic retinopathy in type 2 diabetes: A cohort studyYaxin Wang, Jingyi Lu, Jiaying Ni, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 12, 2021
American Association of Clinical Endocrinology Clinical Practice Guideline: The Use of Advanced Technology in the Management of Persons With Diabetes MellitusGeorge Grunberger, Jennifer Sherr, Myriam Allende, et al.
Pageof 6